Evonik Industries (FRA:EVK) has been given a €31.00 ($36.05) price target by investment analysts at Sanford C. Bernstein in a research report issued to clients and investors on Thursday, Borsen Zeitung reports. The brokerage presently has a “buy” rating on the stock. Sanford C. Bernstein’s price objective would indicate a potential upside of 20.34% from the company’s previous close.
A number of other equities research analysts also recently issued reports on the stock. Warburg Research set a €60.00 ($69.77) price target on shares of Compugroup Medical and gave the stock a “neutral” rating in a report on Tuesday, May 7th. Morgan Stanley set a $70.00 price target on shares of Edison International and gave the stock a “hold” rating in a report on Monday, July 15th. Deutsche Bank raised shares of MGM CHINA HOLDI/ADR to a “buy” rating in a report on Monday, July 1st. Barclays increased their price target on shares of Black Knight from $56.00 to $66.00 and gave the stock an “overweight” rating in a report on Thursday, May 2nd. Finally, HSBC set a €54.00 ($62.79) price target on shares of ADO Properties and gave the stock a “neutral” rating in a report on Wednesday, May 29th. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and ten have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of €30.90 ($35.93).
Shares of Evonik Industries stock opened at €25.76 ($29.95) on Thursday. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34). The stock has a 50-day moving average price of €24.94.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Recommended Story: What is the Difference Between Common Shares and Convertible Shares?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.